“Efficacy and Safety of Ruxolitinib Cream by Anatomic Region in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s453. Accessed July 3, 2025. https://skin.dermsquared.com/skin/article/view/3070.